

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-mediated cell contraction (GO:0070252) | 9.95761655 |
| 2 | skeletal muscle fiber development (GO:0048741) | 8.07485247 |
| 3 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 7.54405625 |
| 4 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.45967513 |
| 5 | actin filament-based movement (GO:0030048) | 7.42636701 |
| 6 | glycogen catabolic process (GO:0005980) | 7.21268348 |
| 7 | striated muscle atrophy (GO:0014891) | 6.92567509 |
| 8 | myotube cell development (GO:0014904) | 6.90012616 |
| 9 | glucan catabolic process (GO:0009251) | 6.76036694 |
| 10 | plasma membrane repair (GO:0001778) | 6.63045692 |
| 11 | skeletal muscle tissue regeneration (GO:0043403) | 6.53580431 |
| 12 | creatine metabolic process (GO:0006600) | 6.51010200 |
| 13 | striated muscle contraction (GO:0006941) | 6.46912869 |
| 14 | carnitine shuttle (GO:0006853) | 6.46533263 |
| 15 | purine nucleotide salvage (GO:0032261) | 6.34145567 |
| 16 | sarcomere organization (GO:0045214) | 6.33352298 |
| 17 | cellular polysaccharide catabolic process (GO:0044247) | 6.30083393 |
| 18 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 6.06805252 |
| 19 | muscle atrophy (GO:0014889) | 6.03743969 |
| 20 | polysaccharide catabolic process (GO:0000272) | 5.96558787 |
| 21 | response to inactivity (GO:0014854) | 5.90132762 |
| 22 | response to muscle activity (GO:0014850) | 5.89762937 |
| 23 | regulation of cell communication by electrical coupling (GO:0010649) | 5.89322488 |
| 24 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.72063246 |
| 25 | myofibril assembly (GO:0030239) | 5.65331870 |
| 26 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.63790985 |
| 27 | striated muscle adaptation (GO:0014888) | 5.55947961 |
| 28 | muscle contraction (GO:0006936) | 5.53956432 |
| 29 | glycogen biosynthetic process (GO:0005978) | 5.46956951 |
| 30 | glucan biosynthetic process (GO:0009250) | 5.46956951 |
| 31 | IMP metabolic process (GO:0046040) | 5.45347187 |
| 32 | fatty acid transmembrane transport (GO:1902001) | 5.42391383 |
| 33 | cytidine deamination (GO:0009972) | 5.20896835 |
| 34 | cytidine metabolic process (GO:0046087) | 5.20896835 |
| 35 | cytidine catabolic process (GO:0006216) | 5.20896835 |
| 36 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.08451904 |
| 37 | muscle system process (GO:0003012) | 4.91390115 |
| 38 | muscle fiber development (GO:0048747) | 4.87601487 |
| 39 | glycogen metabolic process (GO:0005977) | 4.84471553 |
| 40 | carnitine transmembrane transport (GO:1902603) | 4.77355445 |
| 41 | cellular glucan metabolic process (GO:0006073) | 4.74969029 |
| 42 | glucan metabolic process (GO:0044042) | 4.74969029 |
| 43 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.64765967 |
| 44 | cellular response to dexamethasone stimulus (GO:0071549) | 4.52929578 |
| 45 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.50057888 |
| 46 | muscle adaptation (GO:0043500) | 4.49854804 |
| 47 | actomyosin structure organization (GO:0031032) | 4.46590940 |
| 48 | neuronal action potential propagation (GO:0019227) | 4.43227047 |
| 49 | amino-acid betaine transport (GO:0015838) | 4.36919700 |
| 50 | carnitine transport (GO:0015879) | 4.36919700 |
| 51 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.28349200 |
| 52 | IMP biosynthetic process (GO:0006188) | 4.25354676 |
| 53 | response to dexamethasone (GO:0071548) | 4.23702589 |
| 54 | regulation of coenzyme metabolic process (GO:0051196) | 4.23618983 |
| 55 | regulation of cofactor metabolic process (GO:0051193) | 4.23618983 |
| 56 | response to activity (GO:0014823) | 4.09784683 |
| 57 | cellular carbohydrate catabolic process (GO:0044275) | 4.06869713 |
| 58 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.03347849 |
| 59 | negative regulation of skeletal muscle tissue development (GO:0048642) | 4.00267182 |
| 60 | neuromuscular synaptic transmission (GO:0007274) | 3.99733469 |
| 61 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.95160813 |
| 62 | muscle organ development (GO:0007517) | 3.82913361 |
| 63 | negative regulation of muscle hypertrophy (GO:0014741) | 3.80340110 |
| 64 | muscle structure development (GO:0061061) | 3.78119832 |
| 65 | myotube differentiation (GO:0014902) | 3.77390029 |
| 66 | muscle cell cellular homeostasis (GO:0046716) | 3.69801806 |
| 67 | cardiac muscle contraction (GO:0060048) | 3.68193715 |
| 68 | regulation of relaxation of muscle (GO:1901077) | 3.64765808 |
| 69 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.64300845 |
| 70 | tricarboxylic acid cycle (GO:0006099) | 3.59988439 |
| 71 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.57977844 |
| 72 | striated muscle cell development (GO:0055002) | 3.56600509 |
| 73 | skeletal muscle tissue development (GO:0007519) | 3.52741140 |
| 74 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.49135544 |
| 75 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.48875104 |
| 76 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.48875104 |
| 77 | heart contraction (GO:0060047) | 3.46787924 |
| 78 | heart process (GO:0003015) | 3.46787924 |
| 79 | regulation of sulfur metabolic process (GO:0042762) | 3.43461183 |
| 80 | cellular polysaccharide metabolic process (GO:0044264) | 3.39746628 |
| 81 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.36078804 |
| 82 | regulation of actin filament-based movement (GO:1903115) | 3.29106982 |
| 83 | cellular polysaccharide biosynthetic process (GO:0033692) | 3.22458248 |
| 84 | intracellular lipid transport (GO:0032365) | 3.21800822 |
| 85 | positive regulation of myotube differentiation (GO:0010831) | 3.18070795 |
| 86 | polysaccharide biosynthetic process (GO:0000271) | 3.17714157 |
| 87 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.17466780 |
| 88 | polysaccharide metabolic process (GO:0005976) | 3.11847716 |
| 89 | regulation of striated muscle contraction (GO:0006942) | 3.11224953 |
| 90 | positive regulation of myoblast differentiation (GO:0045663) | 3.10615125 |
| 91 | neuromuscular junction development (GO:0007528) | 3.07469380 |
| 92 | myoblast fusion (GO:0007520) | 3.07134444 |
| 93 | quaternary ammonium group transport (GO:0015697) | 3.06634391 |
| 94 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.04813107 |
| 95 | muscle filament sliding (GO:0030049) | 12.1984472 |
| 96 | actin-myosin filament sliding (GO:0033275) | 12.1984472 |
| 97 | regulation of skeletal muscle contraction (GO:0014819) | 12.1586087 |
| 98 | skeletal muscle contraction (GO:0003009) | 11.0183776 |
| 99 | skeletal muscle adaptation (GO:0043501) | 10.9132141 |
| 100 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.6943204 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 9.22369730 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.27171474 |
| 3 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.61632610 |
| 4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.50303096 |
| 5 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.27818129 |
| 6 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.01712777 |
| 7 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.87554822 |
| 8 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.72365476 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.55130275 |
| 10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.52064233 |
| 11 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.48067512 |
| 12 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.48067512 |
| 13 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.07792381 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.03407251 |
| 15 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.89056720 |
| 16 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.85398435 |
| 17 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.83776120 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.75312351 |
| 19 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.68239611 |
| 20 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.66125167 |
| 21 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.65302259 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.61399939 |
| 23 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.61087449 |
| 24 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.59290511 |
| 25 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.56399777 |
| 26 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.48894629 |
| 27 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.45126335 |
| 28 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.44231186 |
| 29 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.39696776 |
| 30 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.38349303 |
| 31 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.37958029 |
| 32 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.37742824 |
| 33 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37345891 |
| 34 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.35818217 |
| 35 | SA1_27219007_Chip-Seq_Bcells_Human | 1.34195317 |
| 36 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32835478 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.31965708 |
| 38 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.31658875 |
| 39 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.29921332 |
| 40 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.28148891 |
| 41 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.27659560 |
| 42 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.25015919 |
| 43 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24833023 |
| 44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.23481301 |
| 45 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.23409329 |
| 46 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.23409329 |
| 47 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.20943277 |
| 48 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.19401740 |
| 49 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.17646013 |
| 50 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.17415882 |
| 51 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.16018903 |
| 52 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.15441692 |
| 53 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.14790045 |
| 54 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.14431149 |
| 55 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.12793083 |
| 56 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.11722478 |
| 57 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.10934508 |
| 58 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.08519392 |
| 59 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.05842648 |
| 60 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.05023335 |
| 61 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.02082014 |
| 62 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.99413823 |
| 63 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.99341455 |
| 64 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.99236017 |
| 65 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.98933570 |
| 66 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.98916059 |
| 67 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98177532 |
| 68 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.98087040 |
| 69 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.98051762 |
| 70 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.97364030 |
| 71 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.96962801 |
| 72 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.95251831 |
| 73 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.93256929 |
| 74 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.93075364 |
| 75 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.92257017 |
| 76 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.91840980 |
| 77 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.91146060 |
| 78 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.90753669 |
| 79 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.90709858 |
| 80 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90008853 |
| 81 | P68_20966046_ChIP-Seq_HELA_Human | 0.89975688 |
| 82 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89516629 |
| 83 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89516629 |
| 84 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.88888239 |
| 85 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.88031398 |
| 86 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87065820 |
| 87 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.87040736 |
| 88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.86797617 |
| 89 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.86717982 |
| 90 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.85747310 |
| 91 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84157524 |
| 92 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.83797901 |
| 93 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.83454650 |
| 94 | CBP_21632823_ChIP-Seq_H3396_Human | 0.83037233 |
| 95 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.82651702 |
| 96 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.82291125 |
| 97 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.81561734 |
| 98 | ATF3_27146783_Chip-Seq_COLON_Human | 0.80988360 |
| 99 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.80487192 |
| 100 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.79264836 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 8.47458492 |
| 2 | MP0003646_muscle_fatigue | 6.57895015 |
| 3 | MP0000749_muscle_degeneration | 6.33272763 |
| 4 | MP0000751_myopathy | 5.51322030 |
| 5 | MP0000747_muscle_weakness | 4.43952468 |
| 6 | MP0002106_abnormal_muscle_physiology | 4.28685837 |
| 7 | MP0004036_abnormal_muscle_relaxation | 4.02126860 |
| 8 | MP0000759_abnormal_skeletal_muscle | 3.86555798 |
| 9 | MP0002269_muscular_atrophy | 3.72224925 |
| 10 | MP0004130_abnormal_muscle_cell | 3.59149929 |
| 11 | MP0005369_muscle_phenotype | 3.55908649 |
| 12 | MP0004087_abnormal_muscle_fiber | 3.38245357 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 3.30911263 |
| 14 | MP0000750_abnormal_muscle_regeneration | 3.22285897 |
| 15 | MP0005620_abnormal_muscle_contractility | 3.10335167 |
| 16 | MP0004233_abnormal_muscle_weight | 2.89060470 |
| 17 | MP0000733_abnormal_muscle_development | 2.37014658 |
| 18 | MP0002332_abnormal_exercise_endurance | 2.28485811 |
| 19 | MP0002108_abnormal_muscle_morphology | 2.01287767 |
| 20 | MP0006036_abnormal_mitochondrial_physio | 2.00200746 |
| 21 | MP0005330_cardiomyopathy | 1.77817476 |
| 22 | MP0004185_abnormal_adipocyte_glucose | 1.71640447 |
| 23 | MP0004084_abnormal_cardiac_muscle | 1.47796054 |
| 24 | MP0004270_analgesia | 1.43013802 |
| 25 | MP0003806_abnormal_nucleotide_metabolis | 1.38669614 |
| 26 | MP0005666_abnormal_adipose_tissue | 1.37804654 |
| 27 | MP0002971_abnormal_brown_adipose | 1.36783819 |
| 28 | MP0003221_abnormal_cardiomyocyte_apopto | 1.22928797 |
| 29 | MP0004215_abnormal_myocardial_fiber | 1.19003340 |
| 30 | MP0004484_altered_response_of | 1.17529534 |
| 31 | MP0002972_abnormal_cardiac_muscle | 1.17028442 |
| 32 | MP0005266_abnormal_metabolism | 1.13681928 |
| 33 | MP0006035_abnormal_mitochondrial_morpho | 1.10749607 |
| 34 | MP0010630_abnormal_cardiac_muscle | 1.10323613 |
| 35 | MP0000013_abnormal_adipose_tissue | 1.05657220 |
| 36 | MP0005375_adipose_tissue_phenotype | 1.04630912 |
| 37 | MP0004134_abnormal_chest_morphology | 0.88099160 |
| 38 | MP0003656_abnormal_erythrocyte_physiolo | 0.87275756 |
| 39 | MP0003950_abnormal_plasma_membrane | 0.82725935 |
| 40 | MP0004147_increased_porphyrin_level | 0.82223018 |
| 41 | MP0004043_abnormal_pH_regulation | 0.81071365 |
| 42 | MP0005385_cardiovascular_system_phenoty | 0.80441443 |
| 43 | MP0001544_abnormal_cardiovascular_syste | 0.80441443 |
| 44 | MP0000372_irregular_coat_pigmentation | 0.79669742 |
| 45 | MP0003705_abnormal_hypodermis_morpholog | 0.74426857 |
| 46 | MP0001299_abnormal_eye_distance/ | 0.74129517 |
| 47 | MP0002234_abnormal_pharynx_morphology | 0.73984725 |
| 48 | MP0009250_abnormal_appendicular_skeleto | 0.72551545 |
| 49 | MP0005334_abnormal_fat_pad | 0.71947199 |
| 50 | MP0003137_abnormal_impulse_conducting | 0.68961800 |
| 51 | MP0008961_abnormal_basal_metabolism | 0.67913849 |
| 52 | MP0002078_abnormal_glucose_homeostasis | 0.66501079 |
| 53 | MP0005670_abnormal_white_adipose | 0.64422572 |
| 54 | MP0000003_abnormal_adipose_tissue | 0.59573384 |
| 55 | MP0000762_abnormal_tongue_morphology | 0.56932080 |
| 56 | MP0005083_abnormal_biliary_tract | 0.55100473 |
| 57 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.54923058 |
| 58 | MP0000266_abnormal_heart_morphology | 0.51000324 |
| 59 | MP0003959_abnormal_lean_body | 0.49457588 |
| 60 | MP0002127_abnormal_cardiovascular_syste | 0.48203976 |
| 61 | MP0005452_abnormal_adipose_tissue | 0.48011386 |
| 62 | MP0002089_abnormal_postnatal_growth/wei | 0.47672066 |
| 63 | MP0008569_lethality_at_weaning | 0.46760427 |
| 64 | MP0004142_abnormal_muscle_tone | 0.45773537 |
| 65 | MP0000343_altered_response_to | 0.45723904 |
| 66 | MP0008775_abnormal_heart_ventricle | 0.45368606 |
| 67 | MP0002896_abnormal_bone_mineralization | 0.42735735 |
| 68 | MP0009672_abnormal_birth_weight | 0.38411617 |
| 69 | MP0005319_abnormal_enzyme/_coenzyme | 0.38360026 |
| 70 | MP0003045_fibrosis | 0.36761721 |
| 71 | MP0003195_calcinosis | 0.35949511 |
| 72 | MP0001849_ear_inflammation | 0.33163963 |
| 73 | MP0002114_abnormal_axial_skeleton | 0.32591094 |
| 74 | MP0003948_abnormal_gas_homeostasis | 0.30283575 |
| 75 | MP0009115_abnormal_fat_cell | 0.30192571 |
| 76 | MP0005376_homeostasis/metabolism_phenot | 0.29850703 |
| 77 | MP0006138_congestive_heart_failure | 0.29109001 |
| 78 | MP0005535_abnormal_body_temperature | 0.27807481 |
| 79 | MP0002118_abnormal_lipid_homeostasis | 0.27684164 |
| 80 | MP0002139_abnormal_hepatobiliary_system | 0.27003442 |
| 81 | MP0000230_abnormal_systemic_arterial | 0.26483531 |
| 82 | MP0008770_decreased_survivor_rate | 0.22575406 |
| 83 | MP0003567_abnormal_fetal_cardiomyocyte | 0.21847236 |
| 84 | MP0004085_abnormal_heartbeat | 0.21579094 |
| 85 | MP0001943_abnormal_respiration | 0.21474541 |
| 86 | MP0002066_abnormal_motor_capabilities/c | 0.21057958 |
| 87 | MP0001853_heart_inflammation | 0.20722575 |
| 88 | MP0005166_decreased_susceptibility_to | 0.19897314 |
| 89 | MP0004859_abnormal_synaptic_plasticity | 0.19480373 |
| 90 | MP0001243_abnormal_dermal_layer | 0.19218093 |
| 91 | MP0000383_abnormal_hair_follicle | 0.18815595 |
| 92 | MP0004510_myositis | 0.18180384 |
| 93 | MP0000678_abnormal_parathyroid_gland | 0.18020330 |
| 94 | MP0005076_abnormal_cell_differentiation | 0.17272243 |
| 95 | MP0003828_pulmonary_edema | 0.17178480 |
| 96 | MP0005275_abnormal_skin_tensile | 0.16851395 |
| 97 | MP0002128_abnormal_blood_circulation | 0.16438535 |
| 98 | MP0002970_abnormal_white_adipose | 0.15062721 |
| 99 | MP0003956_abnormal_body_size | 0.14971384 |
| 100 | MP0002932_abnormal_joint_morphology | 0.14922010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 9.94409134 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.57370164 |
| 3 | Exercise-induced myalgia (HP:0003738) | 8.95265236 |
| 4 | Nemaline bodies (HP:0003798) | 8.86316463 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 8.14881336 |
| 6 | Distal arthrogryposis (HP:0005684) | 7.09047555 |
| 7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 7.03508113 |
| 8 | Type 1 muscle fiber predominance (HP:0003803) | 7.01898530 |
| 9 | Myopathic facies (HP:0002058) | 6.73742203 |
| 10 | Round ear (HP:0100830) | 6.15431922 |
| 11 | Calf muscle hypertrophy (HP:0008981) | 6.14635977 |
| 12 | Ulnar deviation of the wrist (HP:0003049) | 6.05190474 |
| 13 | Difficulty running (HP:0009046) | 5.62615012 |
| 14 | Myoglobinuria (HP:0002913) | 5.45200151 |
| 15 | Calcaneovalgus deformity (HP:0001848) | 5.30313277 |
| 16 | Muscle fiber splitting (HP:0003555) | 5.18611567 |
| 17 | Muscle stiffness (HP:0003552) | 5.08866993 |
| 18 | Absent phalangeal crease (HP:0006109) | 5.01135168 |
| 19 | Deformed tarsal bones (HP:0008119) | 4.78754089 |
| 20 | Hyporeflexia of lower limbs (HP:0002600) | 4.76817441 |
| 21 | Rhabdomyolysis (HP:0003201) | 4.57621094 |
| 22 | EMG: myopathic abnormalities (HP:0003458) | 4.52943292 |
| 23 | Myotonia (HP:0002486) | 4.26639362 |
| 24 | Increased connective tissue (HP:0009025) | 4.20065512 |
| 25 | Abnormal finger flexion creases (HP:0006143) | 4.20002114 |
| 26 | Abnormality of the calf musculature (HP:0001430) | 4.04937099 |
| 27 | Subaortic stenosis (HP:0001682) | 3.71216592 |
| 28 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.71216592 |
| 29 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.64586090 |
| 30 | Malignant hyperthermia (HP:0002047) | 3.60181144 |
| 31 | Rimmed vacuoles (HP:0003805) | 3.53214005 |
| 32 | Shoulder girdle muscle weakness (HP:0003547) | 3.52046859 |
| 33 | Pelvic girdle muscle weakness (HP:0003749) | 3.51608353 |
| 34 | Neck muscle weakness (HP:0000467) | 3.40599108 |
| 35 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.40019966 |
| 36 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.40019966 |
| 37 | Difficulty climbing stairs (HP:0003551) | 3.38257345 |
| 38 | Increased variability in muscle fiber diameter (HP:0003557) | 3.29309564 |
| 39 | Hyperkalemia (HP:0002153) | 3.25067923 |
| 40 | Abnormality of the calcaneus (HP:0008364) | 3.19786200 |
| 41 | Areflexia of lower limbs (HP:0002522) | 3.18983272 |
| 42 | Frequent falls (HP:0002359) | 3.04310540 |
| 43 | Asymmetric septal hypertrophy (HP:0001670) | 2.91558898 |
| 44 | Paralysis (HP:0003470) | 2.74481684 |
| 45 | Abnormality of the neuromuscular junction (HP:0003398) | 2.57381552 |
| 46 | Fatigable weakness (HP:0003473) | 2.57381552 |
| 47 | Sudden death (HP:0001699) | 2.43751618 |
| 48 | Slender build (HP:0001533) | 2.42324037 |
| 49 | EMG: neuropathic changes (HP:0003445) | 2.41551692 |
| 50 | Muscular dystrophy (HP:0003560) | 2.41034676 |
| 51 | Limb-girdle muscle weakness (HP:0003325) | 2.35416262 |
| 52 | Distal lower limb muscle weakness (HP:0009053) | 2.34977542 |
| 53 | Hypoplastic ischia (HP:0003175) | 2.29294243 |
| 54 | Nonprogressive disorder (HP:0003680) | 2.25569448 |
| 55 | Proximal amyotrophy (HP:0007126) | 2.17376873 |
| 56 | Generalized muscle weakness (HP:0003324) | 2.13519611 |
| 57 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.08714299 |
| 58 | Bulbar palsy (HP:0001283) | 2.08051271 |
| 59 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.04230930 |
| 60 | Facial diplegia (HP:0001349) | 2.02908652 |
| 61 | Ulnar deviation of finger (HP:0009465) | 2.01940321 |
| 62 | Abnormality of the ischium (HP:0003174) | 2.00636952 |
| 63 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.98135421 |
| 64 | Gowers sign (HP:0003391) | 1.98117598 |
| 65 | Limb-girdle muscle atrophy (HP:0003797) | 1.97893011 |
| 66 | Metatarsus adductus (HP:0001840) | 1.96264236 |
| 67 | Scapular winging (HP:0003691) | 1.92670495 |
| 68 | Progressive muscle weakness (HP:0003323) | 1.91979110 |
| 69 | Achilles tendon contracture (HP:0001771) | 1.89717678 |
| 70 | Spinal rigidity (HP:0003306) | 1.88856501 |
| 71 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.88687896 |
| 72 | Increased purine levels (HP:0004368) | 1.84666846 |
| 73 | Hyperuricemia (HP:0002149) | 1.84666846 |
| 74 | Distal lower limb amyotrophy (HP:0008944) | 1.83293955 |
| 75 | Weak cry (HP:0001612) | 1.81723391 |
| 76 | Increased density of long bones (HP:0006392) | 1.76356078 |
| 77 | Stridor (HP:0010307) | 1.75189807 |
| 78 | Abnormality of the Achilles tendon (HP:0005109) | 1.73510483 |
| 79 | Waddling gait (HP:0002515) | 1.72842432 |
| 80 | Oligomenorrhea (HP:0000876) | 1.70194002 |
| 81 | Cholelithiasis (HP:0001081) | 1.68835378 |
| 82 | Short palpebral fissure (HP:0012745) | 1.67695324 |
| 83 | Abnormality of potassium homeostasis (HP:0011042) | 1.66698329 |
| 84 | Gout (HP:0001997) | 1.65337750 |
| 85 | Fetal akinesia sequence (HP:0001989) | 1.61130010 |
| 86 | Tarsal synostosis (HP:0008368) | 1.60209297 |
| 87 | Toxemia of pregnancy (HP:0100603) | 1.57539180 |
| 88 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.56956478 |
| 89 | Ventricular tachycardia (HP:0004756) | 1.55284295 |
| 90 | Abnormal gallbladder morphology (HP:0012437) | 1.49889711 |
| 91 | Exercise intolerance (HP:0003546) | 1.46660915 |
| 92 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.45551441 |
| 93 | Adducted thumb (HP:0001181) | 1.45229832 |
| 94 | Hip contracture (HP:0003273) | 1.44401941 |
| 95 | Hypoalphalipoproteinemia (HP:0003233) | 1.44197121 |
| 96 | Long clavicles (HP:0000890) | 1.43916386 |
| 97 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.43829556 |
| 98 | Synostosis involving bones of the feet (HP:0009140) | 1.43829556 |
| 99 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.42653947 |
| 100 | Hypokalemia (HP:0002900) | 1.41779575 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 7.91817912 |
| 2 | TTN | 6.28584485 |
| 3 | PHKG2 | 5.94672244 |
| 4 | PHKG1 | 5.94672244 |
| 5 | NME1 | 4.96406099 |
| 6 | PIK3CG | 3.55857951 |
| 7 | MAP2K3 | 3.07151176 |
| 8 | NEK1 | 2.43801632 |
| 9 | MAP3K7 | 2.28428952 |
| 10 | PINK1 | 2.17534315 |
| 11 | PDK3 | 1.94396910 |
| 12 | PDK4 | 1.94396910 |
| 13 | MAP2K4 | 1.81426886 |
| 14 | TRIB3 | 1.75101646 |
| 15 | DMPK | 1.75082951 |
| 16 | MAPK12 | 1.71711958 |
| 17 | BCKDK | 1.68150543 |
| 18 | PIK3CA | 1.60423870 |
| 19 | MAP2K6 | 1.51891650 |
| 20 | PDK2 | 1.29396420 |
| 21 | MUSK | 1.18376516 |
| 22 | PRKAA2 | 1.01049215 |
| 23 | NEK9 | 1.00749673 |
| 24 | PRKAA1 | 0.95398809 |
| 25 | ERBB3 | 0.81978859 |
| 26 | MAP3K3 | 0.80806955 |
| 27 | TAOK2 | 0.79158168 |
| 28 | TRPM7 | 0.68981301 |
| 29 | ZAK | 0.67157274 |
| 30 | STK24 | 0.65725805 |
| 31 | MAPK11 | 0.61761391 |
| 32 | MAPKAPK3 | 0.59932130 |
| 33 | CAMK2G | 0.58137740 |
| 34 | MAP3K11 | 0.54881928 |
| 35 | AKT2 | 0.54216525 |
| 36 | PKN2 | 0.51161822 |
| 37 | TAOK1 | 0.45769873 |
| 38 | EPHB1 | 0.44466615 |
| 39 | ILK | 0.42158508 |
| 40 | SIK1 | 0.41305898 |
| 41 | PTK6 | 0.39876809 |
| 42 | RIPK1 | 0.38646753 |
| 43 | LIMK1 | 0.37962748 |
| 44 | SGK1 | 0.33677112 |
| 45 | MAP3K6 | 0.33445943 |
| 46 | PKN1 | 0.32327362 |
| 47 | MAP3K10 | 0.31354820 |
| 48 | KSR2 | 0.31064866 |
| 49 | PRKACB | 0.28701544 |
| 50 | EEF2K | 0.27969655 |
| 51 | MAP3K5 | 0.27873913 |
| 52 | RPS6KA3 | 0.27299027 |
| 53 | PNCK | 0.26104248 |
| 54 | PRKG1 | 0.25063249 |
| 55 | INSRR | 0.24861080 |
| 56 | MAP3K1 | 0.24517372 |
| 57 | CAMK1G | 0.23301890 |
| 58 | MAPK7 | 0.21747845 |
| 59 | MAPK4 | 0.21173161 |
| 60 | PRKACA | 0.18875792 |
| 61 | TYK2 | 0.16534133 |
| 62 | PDPK1 | 0.16519979 |
| 63 | PDK1 | 0.15389919 |
| 64 | PAK6 | 0.14441350 |
| 65 | MOS | 0.13918763 |
| 66 | TIE1 | 0.13484089 |
| 67 | ROCK1 | 0.12925467 |
| 68 | MAP2K1 | 0.11685080 |
| 69 | RPS6KA1 | 0.09435476 |
| 70 | PRKD1 | 0.09405544 |
| 71 | CAMK2D | 0.07827224 |
| 72 | BMX | 0.07668270 |
| 73 | PRKACG | 0.07007595 |
| 74 | STK11 | 0.06935924 |
| 75 | MAPK10 | 0.06820032 |
| 76 | SGK3 | 0.06690273 |
| 77 | DYRK1B | 0.06080036 |
| 78 | MAP3K4 | 0.05708143 |
| 79 | ICK | 0.05235715 |
| 80 | CCNB1 | 0.04367978 |
| 81 | MTOR | 0.04090770 |
| 82 | KSR1 | 0.03912073 |
| 83 | TGFBR2 | 0.03713950 |
| 84 | LRRK2 | 0.03701219 |
| 85 | JAK2 | 0.03508757 |
| 86 | LATS2 | 0.02631883 |
| 87 | CSNK1D | 0.02470360 |
| 88 | PTK2B | 0.02218512 |
| 89 | MAPK8 | 0.02137114 |
| 90 | GSK3A | 0.01452252 |
| 91 | FGFR1 | 0.01288901 |
| 92 | ROCK2 | -0.0445426 |
| 93 | PRKCA | -0.0433313 |
| 94 | PRKCB | -0.0420714 |
| 95 | MAP3K8 | -0.0373145 |
| 96 | RPS6KB1 | -0.0296933 |
| 97 | MAPK9 | -0.0139660 |
| 98 | PRKDC | -0.0112573 |
| 99 | RPS6KA2 | -0.0095516 |
| 100 | LATS1 | -0.0029678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.27280797 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.14044970 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.58089931 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.46044476 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.36834879 |
| 6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.21172217 |
| 7 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 3.19208130 |
| 8 | Circadian rhythm_Homo sapiens_hsa04710 | 2.73067044 |
| 9 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.55365727 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.51741560 |
| 11 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.44273847 |
| 12 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.35564415 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 2.23764652 |
| 14 | Insulin resistance_Homo sapiens_hsa04931 | 2.22251368 |
| 15 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.10292661 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.05128836 |
| 17 | Galactose metabolism_Homo sapiens_hsa00052 | 1.87834481 |
| 18 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.85484291 |
| 19 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.84576846 |
| 20 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.74454279 |
| 21 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.73577974 |
| 22 | Parkinsons disease_Homo sapiens_hsa05012 | 1.69644596 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.68022315 |
| 24 | Alzheimers disease_Homo sapiens_hsa05010 | 1.58809296 |
| 25 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.56267651 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.54125876 |
| 27 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.52638030 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.46133558 |
| 29 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.41792651 |
| 30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.40673914 |
| 31 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.38005315 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.37016906 |
| 33 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.35154710 |
| 34 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.22477983 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.20232496 |
| 36 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.17177345 |
| 37 | Tight junction_Homo sapiens_hsa04530 | 1.16629243 |
| 38 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.15668883 |
| 39 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.06161423 |
| 40 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.04237118 |
| 41 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.99871746 |
| 42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.98602855 |
| 43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.95392508 |
| 44 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.94622535 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.93389632 |
| 46 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.85972591 |
| 47 | Focal adhesion_Homo sapiens_hsa04510 | 0.84654178 |
| 48 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83486505 |
| 49 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70962122 |
| 50 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68404068 |
| 51 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67729708 |
| 52 | Huntingtons disease_Homo sapiens_hsa05016 | 0.65932519 |
| 53 | Renin secretion_Homo sapiens_hsa04924 | 0.63831272 |
| 54 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59505028 |
| 55 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.50749510 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.50585560 |
| 57 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49375779 |
| 58 | Insulin secretion_Homo sapiens_hsa04911 | 0.48725459 |
| 59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.48089869 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.45231240 |
| 61 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36213446 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.35884337 |
| 63 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.34209805 |
| 64 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.32056615 |
| 65 | Long-term depression_Homo sapiens_hsa04730 | 0.30889500 |
| 66 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.29513700 |
| 67 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.29210753 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28864264 |
| 69 | Amoebiasis_Homo sapiens_hsa05146 | 0.27108433 |
| 70 | Adherens junction_Homo sapiens_hsa04520 | 0.26407431 |
| 71 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.24181636 |
| 72 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.23681913 |
| 73 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.21668592 |
| 74 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.21017640 |
| 75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.18835507 |
| 76 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.17761439 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.17533585 |
| 78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.17330873 |
| 79 | Long-term potentiation_Homo sapiens_hsa04720 | 0.15608497 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.14987181 |
| 81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.14748992 |
| 82 | Circadian entrainment_Homo sapiens_hsa04713 | 0.13525299 |
| 83 | Purine metabolism_Homo sapiens_hsa00230 | 0.13379335 |
| 84 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.13182366 |
| 85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.12487936 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.12317814 |
| 87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.11899248 |
| 88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.10984216 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.10619300 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10342726 |
| 91 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.08994894 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.07889591 |
| 93 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.07137026 |
| 94 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.06327510 |
| 95 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.05260555 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.04906762 |
| 97 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.04238744 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.03796529 |
| 99 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.02961034 |
| 100 | Bile secretion_Homo sapiens_hsa04976 | 0.02192770 |

